Ignite Creation Date:
2025-12-25 @ 12:04 AM
Ignite Modification Date:
2025-12-25 @ 10:03 PM
Study NCT ID:
NCT05298358
Status:
TERMINATED
Last Update Posted:
2025-02-04
First Post:
2022-03-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-11-18
Start Date Type:
ACTUAL
Primary Completion Date:
2024-11-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-11-21
Completion Date Type:
ACTUAL
First Submit Date:
2022-03-07
First Submit QC Date:
None
Study First Post Date:
2022-03-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-03
Last Update Post Date:
2025-02-04
Last Update Post Date Type:
ACTUAL